Formulary Watch Spotlights
Product Profile: MONJUVI (tafasitamab-cxix injection, for intravenous use)
Product Profile: ZYNYZ (retifanlimab-dlwr injection, for intravenous use)
Product Profile: REXULTI (brexpiprazole tablet)
Product Profile: MIEBO (perfluorohexyloctane ophthalmic solution)
Product Profile: EYELEA HD (aflibercept injection, solution)
Product Profile: TARPEYO (budesonide capsule, delayed release)
Product Profile: WINREVAIR (sotatercept-csrk, for injection, for subcutaneous use)
Product Profile: XDEMVY (lotilaner ophthalmic solution)
Product Profile: ABILIFY ASIMTUFII (aripiprazole injection, suspension, extended release)
Product Profile: AREXVY (respiratory syncytial virus vaccine, adjuvanted)
Product Profile: ABRYSVO (respiratory syncytial virus vaccine)
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Schizophrenia, Bipolar Disorder, and MDD Linked to Increased Risk for Developing Long COVID
2
MHE Week in Review – White House GLP-1 Deal, AI Spots Cancer Risk and More
3
PBMs Make a Case for the GLP-1 Teeter Totter: Up on the Pharmacy Benefit, Down on the Medical One | AMCP Nexus 2025
4
Health Plans Beware: Keep Contract Language Tight If Your PBM Wants Rebate Guarantees Renegotiated Because of the IRA and Biosimilars | AMCP Nexus 2025
5
